CHICAGO – Although clinical progression to AIDS of patients infected with Human immunodeficiency virus (HIV) has declined since the introduction of Highly Active Antiretroviral Therapy (HAART), there ...

Survival of patients with HIV-DLCL has improved in the HAART era, along with CD4 count, whereas survival of similarly treated patients with HIV-BL remained poor. The current practice of using the same ...

Research published in this week's issue of The Lancet highlights the substantial increased survival for people with HIV-1 since the introduction of highly active antiretroviral therapy (HAART) in 1997 ...

Patients with HIV who started highly active antiretroviral therapy (ART) for 6 months had an improved immunohematological profile by the end of the study. Immunohematological parameters were found to ...

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus ...